Effect of naproxen co-administration on valproate disposition (Q73758426)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304722%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Effect of naproxen co-administration on valproate disposition (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304722%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

R S Addison

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304722%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

S L Parker-Scott

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304722%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

W D Hooper

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304722%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M J Eadie

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304722%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

R G Dickinson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304722%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 September 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304722%20AND%20SRC:MED&resulttype=core&format=json

Biopharmaceutics and Drug Disposition

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304722%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304722%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304722%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

235-242

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304722%20AND%20SRC:MED&resulttype=core&format=json

Quantitative metabolic profiling of valproic acid in humans using automated gas chromatographic/mass spectrometric techniques

6 November 2019

cites work

1 reference

Quantitative determination of valproic acid and 14 metabolites in serum and urine by gas chromatography/mass spectrometry

21 January 2018

1 reference

Urinary metabolites of valproic acid in epileptic patients.

21 January 2018

1 reference

Sodium valproate acutely inhibits lamotrigine metabolism

21 January 2018

1 reference

Pharmacokinetic interaction between zidovudine and valproic acid in patients infected with human immunodeficiency virus

21 January 2018

1 reference

The mechanism of the carbamazepine‐valproate interaction in humans

21 January 2018

1 reference

Simultaneous quantitative determination of naproxen, its metabolite 6-O-desmethylnaproxen and their five conjugates in plasma and urine samples by high-performance liquid chromatography on dynamically modified silica

21 January 2018

1 reference

Nonlinear plasma level response to high doses of naproxen

21 January 2018

1 reference

Stereoselective binding properties of naproxen glucuronide diastereomers to proteins

21 January 2018

1 reference

In vivo plasma protein binding interaction between valproic acid and naproxen

21 January 2018

1 reference

Displacement of valproic acid and carbamazepine from protein binding in normal and uremic sera by tolmetin, ibuprofen, and naproxen: presence of inhibitor in uremic serum that blocks valproic acid-naproxen interactions

21 January 2018

1 reference

Urinary excretion of valproate and some metabolites in chronically treated patients

21 January 2018

1 reference

Effect of felbamate on valproic acid disposition in healthy volunteers: inhibition of beta-oxidation

21 January 2018

1 reference

Apparent autoinduction of valproate beta-oxidation in humans

21 January 2018

1 reference

Variability in level-dose ratio of valproate: monotherapy versus polytherapy

21 January 2018

1 reference

Steady-state dispositions of valproate and diflunisal alone and coadministered to healthy volunteers

21 January 2018

1 reference

Studies on the renal excretion of the acyl glucuronide, phenolic glucuronide and sulphate conjugates of diflunisal

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/BDD.235

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304722%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304722%20AND%20SRC:MED&resulttype=core&format=json